Skip to main content
Log in

Drug-induced lipidoses of the cornea and conjunctiva

  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

A variety of lysosomal disorders affect the human cornea and conjunctiva. These disorders may result from inborn abnormalities of a specific intralysosomal enzyme such as the deficit of ceramide trihexosidase in Fabry's disease. Alternately, lysosomal dysfunction may be the result of drug administration with subsequent drug-induced lipidosis. Chloroquine, amiodarone, amodiaquine, benoquin, tilorone, and gentamicin are lipidosis-inducing drugs with proven involvement of the human cornea and conjunctiva. Similarities between Fabry's disease and the drug-induced lipidoses include intraepithelial corneal deposits frequently arranged in a verticillate or vortex pattern, and the presence of abnormal inclusions of intralysosomal lipid in corneal and conjunctival tissue when examined by transmission electron microscopy. These striking parallels invite consideration of lysosomal dysfunction as a factor in the recognized or potential toxicity of drugs inducing lipidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abraham, R. & R.J. Hendy. Irreversible lysosomal damage induced by chloroquine in the retinas of pigmented and albino rats. Exp. Mol. Pathol. 12: 185 (1970).

    Google Scholar 

  2. Anderson, B. Corneal and conjunctival pigmentation among workers engaged in the manufacture of hydroquinone. Arch. Ophthalmol. 38: 812 (1947).

    Google Scholar 

  3. Babel, J. & N. Stangos. Lesions oculaires iatrogenes; L'action d'un nouveau medcament contre l'angor pectoris. Arch. Ophtalmol. 30: 197 (1970).

    Google Scholar 

  4. Blanke, R.V., J.J. Saady, D.C. Drummond & J.N. Weiss. Tilorone determination in a corneal biopsy. J. Analytical Toxicol. 9/10: 206 (1979).

    Google Scholar 

  5. Bleil, D.C. Unusual toxic manifestations to amodiaquin (Camoquin). Arch. Derm. 77: 106 (1958).

    Google Scholar 

  6. Bockhardt, H., D. Drenckhahn & R. Lullmann-Rauch. Amiodarone-induced lipidosis-like alterations in ocular tissues of rats. Albrecht von Graefes Arch. klin. exp. Ophthal. 207: 91 (1978).

    Google Scholar 

  7. Brady, R.O., A.E. Gal, R.M. Bradley, E. Martensson, A.L. Warshaw & L. Laster. Enzymatic defect in Fabry's disease: ceramide trihexosidase deficiency. N. Eng. J. Med. 276: 1163 (1967).

    Google Scholar 

  8. Calkins, L.L. Corneal epithelial changes occurring during chloroquine (Aralen) therapy. Arch. Ophthalmol. 60: 981 (1958).

    Google Scholar 

  9. Carr, R.E., P. Henkind, N. Rothfield & I.M. Siegel. Ocular toxicity of antimalarial drugs. Am. J. Ophthalmol. 66: 738 (1968).

    Google Scholar 

  10. D'Amico, D.J., K.R. Kenyon & J.N. Ruskin. Amiodarone keratopathy: a drug-induced lipid storage disorder. Arch. Ophthalmol. 99: 257 (1981).

    Google Scholar 

  11. Delage, C., R. Lagace & J. Huard. Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study. Can. Med. Assoc. J. 112: 1205 (1975).

    Google Scholar 

  12. Deodati, F., P. Bec, G. Cuz et al. Thesaurismose corneene par traitement au chlorhydrate d'amiodarone. A propos de 13 observations. Bull. Soc. Ophtalmol. Fr. 69: 967 (1969).

    Google Scholar 

  13. Font, R. & B. Fine. Ocular pathology in Fabry's disease. Histochemical and electron microscopic observations. Am. J. Ophthalmol. 73: 419 (1972).

    Google Scholar 

  14. François, J. Cornea verticillata. Bull. Soc. Belge. Ophtalmol. 150: 656 (1968).

    Google Scholar 

  15. Frost, P., Y. Tanaka & G.L. Spaeth. Fabry's disease. Glycolipid lipidosis: histochemical and electron microscopic studies of two cases. Am. J. Med. 40: 618 (1966).

    Google Scholar 

  16. Hedges, T.R., K.R. Kenyon & D.B. Moser. The ocular effects of the monobenzyl ether of hydroquinone in patients with vitiligo. In preparation.

  17. Hirst, L., G. Sanborn, N. Miller & W. Green. Amodiaquine (Camoquin) keratopathy. A clinico-pathologic case report. In preparation.

  18. Houhgton, D.C., M. Hartnett, M. Campbell-Boswell, G. Porter & W. Bennett. A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am. J. Pathol. 82: 589 (1976).

    Google Scholar 

  19. Kozek, J.C. R.I. Mazze & M.J. Cousins. Nephrotoxicity of gentamicin. Lab. Invest. 30: 48 (1974).

    Google Scholar 

  20. Libert, J. Diagnostic des malades lysosomiales de stockage, par l'etude de la biopsie conjonctivale en microscope electronique. Thesis, Universite Libre de Bruxelles, 1979.

  21. Libert, J., P.E. Ketelbant-Balasse, F. van Hoof, G. Aubert-Tulkens & P. Tulkens. Cellular toxicity of gentamicin. Am. J. Ophthalmol. 87: 405 (1979).

    Google Scholar 

  22. Libert, J., M. Tondeur & F. van Hoof. The use of conjunctival biopsy and enzyme analysis in tears of the diagnosis of homozygotes and heterozygotes with Fabry disease. Birth Defects 12: 221 (1976).

    Google Scholar 

  23. Lullmann, H., R. Lullmann-Rauch & O. Wassermann. Drug-induced phospholipidoses. Crit. Rev. Toxicol. 4: 185 (1975).

    Google Scholar 

  24. Lullmann, H., R. Lullmann-Rauch & O. Wassermann. Lipidosis induced by amphiphilic cationic drugs. Biochem. Pharmac. 27: 1103 (1978).

    Google Scholar 

  25. Maguire, A. Amodiaquine hydrochloride. Lancet 1: 667 (1962).

    Google Scholar 

  26. Maguire, A. & H. Kolb. The effect of a synthetic antimalarial (amodiaquine) on the retina. Brit. J. Derm. 76: 471 (1964).

    Google Scholar 

  27. McKusick, V.A. Heritable Disorders of Connective Tissue. C.V. Mosby Company, St. Louis, Missouri, p. 642 (1972).

    Google Scholar 

  28. Naumann, G. Corneal damage in hydroquinone workers. Arch. Ophthalmol. 76: 189 (1966).

    Google Scholar 

  29. Nylander, V. Ocular damage in chloroquine therapy. Acta Ophthalmol. 92: 1 (1967).

    Google Scholar 

  30. Percival, S.P.B. & J. Behrman. Ophthalmological safety of chloroquine. Brit. J. Ophthalmol. 53: 101 (1969).

    Google Scholar 

  31. Pulhorn, G. & H.-J. Thiel. Das ultrastrukturelle bild der chloroquin-keratopathie. Albrecht v. Graefes Arch. klin. exp. Ophthal 201: 89 (1976).

    Google Scholar 

  32. Ramsey, M.S. & B.S. Fine. Chloroquine toxicity in the human eye. Am. J. Ophthalmol. 73: 229 (1972).

    Google Scholar 

  33. Rosenbaum, M.B., P.A. Chiale, M.S. Halpern et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am. J. Cardiol. 38: 934 (1976).

    Google Scholar 

  34. Rosenthal, A.R., H. Kolb, D. Bergsma, D. Huxsoll & J.L. Hopkins. Chloroquine retinopathy in the rhesus monkey. Invest. Ophthalmol. Visual Sci. 17: 1158 (1978).

    Google Scholar 

  35. Schmalbruch, H. The early changes in experimental myopathy induced by chloroquine and chlorphentermine. J. Neuropathol. Exp. Neurol. 39: 65 (1980).

    Google Scholar 

  36. Spaeth, G.L. & P. Frost. Fabry's disease: its ocular manifestations. Arch. Ophthalmol. 74: 760 (1965).

    Google Scholar 

  37. Toussaint, D. & S. Pohl. Aspect histologique et ultrastructure des depots corneens dus au chlorhydrate d'amiodarone. Bull. Soc. Belge Ophtalmol. 153: 675 (1969).

    Google Scholar 

  38. Tulkens, P. & A. Trouet. Uptake and intracellular localization of kanamycin and gentamicin in the lysosomes of cultured fibroblasts. Arch. Int. Physiol. Biochim. 82: 1018 (1974).

    Google Scholar 

  39. Van Hoof, F., J. Libert, G. Aubert-Tulkens & M.V. Serra. The assay of lacrymal enzymes and the ultrastructural analysis of conjunctival biopsies. New techniques for the study of inborn lysosomal diseases. Metab. Ophthalmol. 1: 165 (1977).

    Google Scholar 

  40. Watillon, M., G. Lavergne & J.F. Weekers. Lesions corneens au cours du traitement par le cordarone (chlorhydrate d'amiodarone). Bull. Soc. Belge Ophtalmol. 150: 715 (1968).

    Google Scholar 

  41. Watson, I.B. & D.G. MacDonald. Amodioquine-induced oral pigmentation - a light and electron microscopic study. J. Oral Path. 3: 16 (1974).

    Google Scholar 

  42. Weiss, J.N., A.L. Ochs, S. Abedi & J.B. Selhorst. Retinopathy following tilorone hydrochloride. Am. J. Ophthalmol. 90: 846 (1980).

    Google Scholar 

  43. Weiss, J.N., R.S. Weinberg & W. Regelson. Keratopathy after oral administration of tilorone hydrochloride. Am. J. Ophthalmol. 89: 46 (1980).

    Google Scholar 

  44. Wise, D., H.J. Wallace & E.H. Jellinck. Angiokeratoma corporis diffusum: A clinical study of eight affected families. Q. J. Med. 31: 177 (1962).

    Google Scholar 

  45. Zipes, D.P. & P.J. Troup. New antiarrhythmic agents, amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil. Am. J. Cardiol. 41: 1005 (1978).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by Academic Investigator Award EY00156 from the National Eye Institute, NIH; a grant-in-aid from Fight For Sight, Inc., NYC; the Research to Prevent Blindness James S. Adams Award; Biomedical Research Support Grant RR05527 from the National Eye Institute, NIH; and the Massachusetts Lions Eye Research Fund, Inc. (Dr. Kenyon).

Rights and permissions

Reprints and permissions

About this article

Cite this article

D'amico, D.J., Kenyon, K.R. Drug-induced lipidoses of the cornea and conjunctiva. Int Ophthalmol 4, 67–76 (1981). https://doi.org/10.1007/BF00139581

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00139581

Keywords

Navigation